Literature DB >> 33403591

Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats.

Lyubka Tancheva1,2, Maria Lazarova2, Luciano Saso3, Reni Kalfin4, Miroslava Stefanova2, Diamara Uzunova2, Atanas G Atanasov2,5,6,7.   

Abstract

Previous evidence has shown a link between neurodegenerative diseases, including Parkinson's disease (PD), and melatonin. The data in the literature about the impact of the hormone under different experimental PD conditions are quite controversial, and its effect on memory impairment in the disease is very poorly explored. The current research was aimed at investigating the role of melatonin pretreatment on memory and motor behavior in healthy rats and those with the partial 6-hydroxydopamine (6-OHDA) model of PD. All rodents were pretreated with melatonin (20 mg/kg, intraperitoneally) for 5 days. At 24 h and 7 days after the first treatment for healthy rats, and at the second and third week post-lesion for those with PD, the animals were tested behaviorally (apomorphine-induced rotations, rotarod, and passive avoidance tests). The neurochemical levels of dopamine (DA), acetylcholine (ACh), noradrenaline (NA), and serotonin (Sero) in the brain were also determined. The results showed that in healthy animals, melatonin pretreatment had amnestic and motor-suppressive effects and did not change the levels of measured brain neurotransmitters. In animals with PD, melatonin pretreatment exerted a neuroprotective effect, manifested as a significantly decreased number of apomorphine-induced rotations, reduced number of falls in the rotarod test, and improved memory performance. The brain DA and ACh concentrations in the same animals were restored to the control levels, and those of NA and Sero did not change. Our results demonstrate a beneficial effect of melatonin on memory and motor disturbance in 6-OHDA-lesioned rats.

Entities:  

Keywords:  6-OHDA; Beneficial effect; Melatonin; Memory; Parkinson’s disease

Year:  2021        PMID: 33403591     DOI: 10.1007/s12031-020-01760-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  49 in total

1.  Study of circadian melatonin secretion pattern at different stages of Parkinson's disease.

Authors:  R Bordet; D Devos; S Brique; Y Touitou; J D Guieu; C Libersa; A Destée
Journal:  Clin Neuropharmacol       Date:  2003 Mar-Apr       Impact factor: 1.592

2.  Melatonin modulates apomorphine-induced rotational behaviour.

Authors:  S Burton; S Daya; B Potgieter
Journal:  Experientia       Date:  1991-05-15

Review 3.  Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.

Authors:  D Blum; S Torch; N Lambeng; M Nissou; A L Benabid; R Sadoul; J M Verna
Journal:  Prog Neurobiol       Date:  2001-10       Impact factor: 11.685

Review 4.  Free radicals and the pathobiology of brain dopamine systems.

Authors:  J L Cadet; C Brannock
Journal:  Neurochem Int       Date:  1998-02       Impact factor: 3.921

5.  Melatonin reverses neurochemical alterations induced by 6-OHDA in rat striatum.

Authors:  L M V Aguiar; S M M Vasconcelos; F C F Sousa; G S B Viana
Journal:  Life Sci       Date:  2002-01-18       Impact factor: 5.037

6.  Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.

Authors:  Fabio Blandini; Giovanna Levandis; Eleonora Bazzini; Giuseppe Nappi; Marie-Therese Armentero
Journal:  Eur J Neurosci       Date:  2007-01       Impact factor: 3.386

7.  Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1996-08       Impact factor: 17.088

8.  Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents.

Authors:  Anupom Borah; Kochupurackal P Mohanakumar
Journal:  J Pineal Res       Date:  2009-10-01       Impact factor: 13.007

9.  Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats.

Authors:  Taysa B Bassani; Raisa W Gradowski; Tiago Zaminelli; Janaína K Barbiero; Ronise M Santiago; Suelen L Boschen; Claudio da Cunha; Marcelo M S Lima; Roberto Andreatini; Maria A B F Vital
Journal:  Brain Res       Date:  2014-10-06       Impact factor: 3.252

10.  Memory facilitating effects of agomelatine in the novel object recognition memory paradigm in the rat.

Authors:  Valérie Bertaina-Anglade; Christophe Drieu-La-Rochelle; Elisabeth Mocaër; Laure Seguin
Journal:  Pharmacol Biochem Behav       Date:  2011-02-22       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.